Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Abstract: A method of determining the presence of FcRH5 in a biological sample suspected of containing FcRH5 is provided comprising exposing the biological sample to an isolated monoclonal anti-FcRH5 antibody.

Abstract: Systems and methods for providing a vehicular navigation control interface are included in the present disclosure. Some embodiments include a navigation system and a vehicle with a vehicle control module (VCM), a navigation control module (NCM), and a navigation control interface, where the VCM receives a manual command from an operator to implement a manual control function. In some embodiments the NCM receives an automatic command from the navigation system to implement an automatic control function via the VCM and the navigation control interface directly connects the VCM and the NCM to facilitate communication between the VCM and NCM for implementing automatic mode and for reporting implementation of a manual mode.

Abstract: Included are embodiments for providing vehicle control limits. One embodiment of a system includes a navigation system and a vehicle that includes a memory component that stores a program. Embodiments of the system are configured to receive an indication for automatic control of the vehicle, receive a route for the vehicle to reach a destination for completing a work order from the navigation system, and determine a vehicle limit, wherein the vehicle limit is based on a current state of the vehicle. Some embodiments are configured to communicate the vehicle limit from a vehicle control module (VCM) to a navigation control module (NCM), determine, via the NCM, an automatic command based on the destination and the vehicle limit and send the automatic command to a motor of the vehicle.

Abstract: Included are embodiments for providing vehicle control limits. One embodiment of a system includes a navigation system and a vehicle that includes a memory component that stores a program. Embodiments of the system are configured to receive an indication for automatic control of the vehicle, receive a route for the vehicle to reach a destination for completing a work order from the navigation system, and determine a vehicle limit, wherein the vehicle limit is based on a current state of the vehicle. Some embodiments are configured to communicate the vehicle limit from a vehicle control module (VCM) to a navigation control module (NCM), determine, via the NCM, an automatic command based on the destination and the vehicle limit and send the automatic command to a motor of the vehicle.

Abstract: Included are systems and methods for providing a vehicular navigation control interface. Some embodiments include a navigation system and a vehicle with a vehicle control module (VCM), a navigation control module (NCM), and a navigation control interface, where the VCM receives a manual command from an operator to implement a manual control function. In some embodiments the NCM receives an automatic command from the navigation system to implement an automatic control function via the VCM and the navigation control interface directly connects the VCM and the NCM to facilitate communication between the VCM and NCM for implementing automatic mode and for reporting implementation of a manual mode.

Abstract: Included are embodiments for providing vehicle control limits. One embodiment of a system includes a navigation system and a vehicle that includes a memory component that stores a program. Embodiments of the system are configured to receive an indication for automatic control of the vehicle, receive a route for the vehicle to reach a destination for completing a work order from the navigation system, and determine a vehicle limit, wherein the vehicle limit is based on a current state of the vehicle. Some embodiments are configured to communicate the vehicle limit from a vehicle control module (VCM) to a navigation control module (NCM), determine, via the NCM, an automatic command based on the destination and the vehicle limit and send the automatic command to a motor of the vehicle.

Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Abstract: The present invention is directed to compositions of matter comprising nucleic acids encoding a polypeptide comprising the amino acid sequence of SEQ ID NO: 207 or 208, encoding an anti-CD79b antibody comprising the heavy chain variable domain sequence of SEQ ID NO: 207 and the light chain variable domain sequence of SEQ ID NO: 208, or encoding an anti-CD79b antibody having : (i) a variable light chain comprising a HVR-L1 having the sequence of SEQ ID NO: 194, a HVR-L2 having the sequence of SEQ ID NO: 195, and a HVR-L3 having the sequence of SEQ ID NO: 196 and (ii) a variable light chain comprising a HVR-H1 having the sequence of SEQ ID NO: 202, a HVR-H2 having the sequence of SEQ ID NO: 203, and a HVR-H3 having the sequence of SEQ ID NO: 204, and vectors and host cells thereof.

Abstract: Systems and methods for providing a vehicular navigation control are disclosed herein. Some embodiments include a navigation system and a vehicle with a vehicle control module (VCM), a navigation control module (NCM), and a navigation control interface, where the VCM receives a manual command from an operator to implement a manual control function. In some embodiments the NCM receives an automatic command from the navigation system to implement an automatic control function via the VCM and the navigation control interface directly connects the VCM and the NCM to facilitate communication between the VCM and NCM for implementing automatic mode and for reporting implementation of a manual mode.

Abstract: Provided are system and method for performing access screening in a CDMA network. In one embodiment, the method comprises comparing a strength of a reference pilot specified in an origination message (“ORM”) received from the mobile unit to at least one of an upper pilot strength threshold (“UPST”) and a lower pilot strength threshold (“LPST”); responsive to the reference pilot strength failing to exceed the LPST, redirecting the mobile unit; responsive to the reference pilot strength exceeding the LPST but failing to exceed the UPST, determining whether an additional pilot is reported having a strength greater than that of the reference pilot; and responsive to a determination that no additional pilot is reported having a strength greater than that of the reference pilot, redirecting the mobile unit.

Abstract: The invention provides anti-CD79b antibodies and immunoconjugates and methods of using the same.

Abstract: The invention provides anti-CD22 antibodies and immunoconjugates and methods of using the same.

Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Abstract: The present invention is directed to compositions of matter comprising immunoconjugates comprising an anti-CD79b antibody comprising: (i) an HVR-L1 sequence of KASQSVDYEGDSFLN (SEQ ID NO: 194), (ii) an HVR-L2 sequence of AASNLES (SEQ ID NO: 195), (iii) an HVR-L3 sequence of QQSNEDPLT (SEQ ID NO: 196), (iv) an HVR-H1 sequence of GYTFSSYWIE (SEQ ID NO: 202), (v) an HVR-H2 sequence of GEILPGGGDTNYNEIFKG (SEQ ID NO: 203), and (vi) an HVR-H3 sequence of TRRVPIRLDY (SEQ ID NO: 204) and to methods of using those compositions of matter for the treatment of hematopoietic tumor in mammals.

Abstract: Provided are system and method for performing access screening in a CDMA network. In one embodiment, the method comprises comparing a strength of a reference pilot specified in an origination message (“ORM”) received from the mobile unit to at least one of an upper pilot strength threshold (“UPST”) and a lower pilot strength threshold (“LPST”); responsive to the reference pilot strength failing to exceed the LPST, redirecting the mobile unit; responsive to the reference pilot strength exceeding the LPST but failing to exceed the UPST, determining whether an additional pilot is reported having a strength greater than that of the reference pilot; and responsive to a determination that no additional pilot is reported having a strength greater than that of the reference pilot, redirecting the mobile unit.

Abstract: The present invention is directed to compositions of matter useful for the treatment of hematopoietic tumor in mammals and to methods of using those compositions of matter for the same.

Abstract: Anti-FcRH5 antibodies and immunoconjugates thereof are provided. Methods of using anti-FcRH5 antibodies and immunoconjugates thereof are provided.